Release Date: 11/05/12 09:37 Summary: Reports 2012 Q1 Rev of US$26.3 M vs US$18.0M in Q1 of 2011 Price Sensitive: Yes Download Document 250.99KB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status